Trial Profile
A Multicenter, Prospective, Randomized Controlled Clinical Trial Comparing Endostar With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 29 Sep 2016 New trial record